Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Glomerulonephritis minimal lesion
ADR ID BADD_A01851
ADR Hierarchy
20      Renal and urinary disorders
20.05      Nephropathies
20.05.01      Glomerulonephritis and nephrotic syndrome
20.05.01.011      Glomerulonephritis minimal lesion
Description A kidney disease with no or minimal histological glomerular changes on light microscopy and with no immune deposits. It is characterized by lipid accumulation in the epithelial cells of KIDNEY TUBULES and in the URINE. Patients usually show NEPHROTIC SYNDROME indicating the presence of PROTEINURIA with accompanying EDEMA. [MeSH]
MedDRA Code 10018374
MeSH ID D009402
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Glomerulonephritis minimal lesion | Minimal change glomerulonephritis | Lipoid nephrosis | Minimal change disease | Nephrosis, Lipoid | Lipoid Nephroses | Lipoid Nephrosis | Nephroses, Lipoid | Minimal Change Glomerulopathy | Minimal Change Disease | Change Diseases, Minimal | Disease, Minimal Change | Diseases, Minimal Change | Minimal Change Diseases | Nephropathy, Minimal Change | Minimal Change Nephropathies | Minimal Change Nephropathy | Nephropathies, Minimal Change | Glomerulopathy, Minimal Change | Glomerulopathies, Minimal Change | Idiopathic Minimal Change Nephrotic Syndrome | Nephrotic Syndrome, Minimal Change | Minimal Change Nephrotic Syndrome | Glomerulonephritis, Minimal Change | Glomerulonephritides, Minimal Change | Minimal Change Glomerulonephritides | Minimal Change Glomerulonephritis
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00410Celecoxib--
BADD_D00589Dasatinib0.000168%
BADD_D00653Diclofenac0.000051%
BADD_D01120Ibuprofen0.000017%
BADD_D01204Isoniazid0.006949%
BADD_D01265Levetiracetam0.000994%
BADD_D01397Mesalamine--
BADD_D01662Pamidronic acid0.000126%
BADD_D02105Tacrolimus0.000446%
The 1th Page    1    Total 1 Pages